Nektar Therapeutics
Polymer-sunitinib conjugates

Last updated:

Abstract:

The invention relates to (among other things) polymer-sunitinib conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over sunitinib in unconjugated form.

Status:
Grant
Type:

Utility

Filling date:

7 May 2020

Issue date:

23 Aug 2022